All filters
Slidesets
Use of Integrase Inhibitors in special populations | Omar Sued, MSc, MD, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
Clinical use of Integrase Inhibitors | Eugenia Negredo, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
Use of Integrase Inhibitors in Latin America | Mônica Jacques de Moraes, MD, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
Clinical case presentation | Eugenia Negredo, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
Dual therapy regimens | Maria Ines Figueroa, MD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
HIV Integrase Inhibitors: A new mechanism of action | Charles Boucher, MD, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
Pharmacology and new modes of delivery | David Back, PhD
Presented at:
Argentina HIV Clinical Forum 2018
Slidesets
Clinical Case presentation | Elena Orlova-Morozova, PhD
Presented at:
Russian HIV Clinical Forum 2018
Slidesets
Two Drug Regimens - Pros and Cons | Jürgen Rockstroh, MD
Presented at:
Russian HIV Clinical Forum 2018
Slidesets
Abstract: A pharmacometric framework for dose individualisation of sunitinib in GIST (#O2) | Maddalena Centanni
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018
Slidesets
Rationale for selecting combinations with immunotherapy | Howard Gurney, MBBS, FRACP
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018
Slidesets
Immunotherapy of prostate cancer and urothelial cancer. Future directions | Winald Gerritsen, MD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018